product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
PANK3 Antibody (OTI3C4) - Azide and BSA Free
catalog :
NBP2-73244
quantity :
100 ug
price :
579 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI3C4
reactivity :
human, mouse, rat
application :
western blot, flow cytometry
more info or order :
product information
master code :
NBP2-73244
SKU :
NBP2-73244
product name :
PANK3 Antibody (OTI3C4) - Azide and BSA Free
unit size :
100 ug
description :
The PANK3 Antibody (OTI3C4) - Azide and BSA Free from Novus is a mouse monoclonal antibody to PANK3. This antibody reacts with human,mouse,rat. The PANK3 Antibody (OTI3C4) - Azide and BSA Free has been validated for the following applications: Flow Cytometry,Western Blot,CyTOF-ready.
target :
PANK3
category :
Primary Antibodies
buffer :
Lyophilized from PBS (pH 7.3) with 8% Trehalose
clonality :
Monoclonal
clone :
OTI3C4
concentration :
LYOPH
conjugate :
Unconjugated
host :
Mouse
immunogen :
Full length human recombinant protein of human PANK3 (NP_078870) produced in HEK293T cell.
isotype :
IgG1
purity :
Immunogen affinity purified
species :
Human,Mouse,Rat
theoretical molecular weight :
40.9 kDa
gene symbol :
PANK3
applications :
Flow Cytometry,Western Blot,CyTOF-ready
USD :
579 USD
alt names :
DKFZp686O22247, EC 2.7.1.33, FLJ12899, hPanK3, MGC16863, pantothenate kinase 3, Pantothenic acid kinase 3
storage :
Store at -20C. Avoid freeze-thaw cycles.
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
browse more products
questions and comments